Chaitan S. Khosla
Chairman of Scientific Advisory BoardDr. Chaitan S. Khosla, Ph.D. serves as Technical Advisor of Joule Unlimited, Inc. Dr. Khosla is the Founder at Sitari Pharmaceuticals, Inc. and Flamentera AG. He served as an Independent Director of Entero Therapeutics, Inc. (formerly known as First Wave BioPharma, Inc.) since March 13, 2024 until August 16, 2024. He serves as an Advisor of LS9 Inc. He serves as Technical Advisor of Joule Unlimited, Inc. He co-founded Kosan Biosciences Incorporated. He is an Inventor of the combinatorial biosynthesis technology that Kosan Biosciences Incorporated licensed from Stanford University. He was a Scientific Founder of Alvine Pharmaceuticals from 2005 until 2016. He was an Advisor at REG Life Sciences, LLC. He joined Stanford in 1992. He was also the Founding President of the non-profit Celiac Sprue Research Foundation. He serves as the Chairman of the Scientific Advisory Board of Kosan Biosciences Inc. He served as Co-Chairman of Scientific Advisory Board and was Director of Kosan Biosciences Incorporated since January 1995 until 2008. He served as an Independent Director at Protagonist Therapeutics, Inc. since October 2014 until August 2020 and has been its Scientific Advisor since 2015. He is Chairman of Scientific Advisory Board at Protagonist Therapeutics, Inc. He serves as a Director of Alvine Pharmaceuticals, Inc. from 2005 until 2016. He served as a Member of Scientific Advisory Board of LS9 Inc. He served as Member of Scientific Advisory Board at REG Life Sciences, LLC. He has been a Professor of Chemical Engineering, Chemistry and Biochemistry of Stanford University since 2001 and has been a Faculty Member since 1992. Since 2013, he has served as the founding Director of Stanford ChEM-H. He is a Professor of Chemistry, Chemical Engineering and Biochemistry of Stanford University. He has co-authored over 300 publications and is the recipient of several awards and honors including a National Science Foundation Young Investigator Award, a David and Lucile Packard Fellowship for Science and Engineering, the Allan P. Colburn Award from the American Institute of Chemical Engineers, the 1999 Eli Lilly Award in Biological Chemistry and the 2000 ACS Award in Pure Chemistry from the American Chemical Society and the 1999 Alan T. Waterman Award from the National Science Foundation. He is also the recipient of a Distinguished Alumnus Award from his Undergraduate and Graduate alma maters. Dr. Khosla is an elected member of the American Academy of Arts & Sciences and the National Academy of Engineering. He also holds Postdoctoral studies from the John Innes Centre in the UK. He is an inventor on over 75 issued U.S. patents. Dr. Khosla received a B.S. Tech. from the Indian Institute of Technology, Mumbai, India and a Ph.D. from the California Institute of Technology in 1990.
Positions
- Company NameProtagonist Therapeutics, Inc.Stock CodePTGXPositionChairman of Scientific Advisory BoardColleagues
- DVDinesh V. PatelCEO, President, Secretary & Director
- HEHarold E. SelickIndependent Chairman
- AAAsif AliExecutive VP & CFO
- AMArturo M. MolinaChief Medical Officer
- VTVenkat ThalladiEVP & Chief Technical Officer
- NYNewman YeildingExecutive VP, Chief Scientific Officer
- WDWilliam D. WaddillIndependent Director
- BGBryan GiraudoIndependent Director
